![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 21, 15741-15748, May 26, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From Ruhr-Universität Bochum, Medizinische Fakultät,
Abteilung für Virologie, Universitätsstrasse 150, Gebäuole MA 6/130, D-44780 Bochum, Germany, the
Expression of the cysteine-rich fibroblast growth
factor (FGF) receptor (CFR) in COS-1 cells strongly inhibits the
secretion of co-expressed FGF3. By using a column retention assay and
affinity chromatography, we demonstrate that at physiological salt
concentrations FGF3 binds with strong affinity to CFR in
vivo and in vitro. Furthermore, to show that FGF3
binds to CFR in vivo, truncation mutants of CFR with
changed subcellular distributions were shown to cause a similar
redistribution of FGF3. Although CFR is a 150-kDa integral membrane
glycoprotein that is primarily located in the Golgi apparatus, we show
here that in COS-1 cells a substantial proportion of CFR is secreted.
This is due to a carboxyl-terminal proteolytic cleavage that releases
the intraluminal portion of the protein for secretion. However, the
apparent size of the integral membrane and secreted CFR appears
similar, since the loss of protein mass is balanced by a gain of
complex carbohydrates. The released CFR is associated with the
extracellular matrix through its affinity for glycosaminoglycans. These findings show that CFR can modulate the secretion of FGF3 and may
control its biological activity by regulating its secretion.
Cysteine-rich Fibroblast Growth Factor Receptor Alters Secretion
and Intracellular Routing of Fibroblast Growth Factor 3*
,
Department of Molecular, Cellular, and Developmental
Biology, University of Colorado, Boulder, Colorado 80308, and
§ Imperial Cancer Research Fund Laboratories, 44 Lincoln's
Inn Fields, London WC2A 3PX, United Kingdom
*
This work was supported by a grant from the National
Institutes of Health (to B. B. O.) and by a grant from the German
Research Society (to P. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
J. Ahn, M. Febbraio, and R. L. Silverstein A novel isoform of human Golgi complex-localized glycoprotein-1 (also known as E-selectin ligand-1, MG-160 and cysteine-rich fibroblast growth factor receptor) targets differential subcellular localization J. Cell Sci., April 15, 2005; 118(8): 1725 - 1731. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wilkinson, G. Kolle, D. Wen, M. Piper, J. Scott, and M. Little CRIM1 Regulates the Rate of Processing and Delivery of Bone Morphogenetic Proteins to the Cell Surface J. Biol. Chem., September 5, 2003; 278(36): 34181 - 34188. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Reimers, M. Antoine, M. Zapatka, V. Blecken, C. Dickson, and P. Kiefer NoBP, a Nuclear Fibroblast Growth Factor 3 Binding Protein, Is Cell Cycle Regulated and Promotes Cell Growth Mol. Cell. Biol., August 1, 2001; 21(15): 4996 - 5007. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |